MedTrace Logo

Peritoneal Surface Malignancies - Characterization, Models and Treatment Strategies

NCT02073500 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-07-28

No results posted yet for this study

Summary

The aim of this study is to identify biomarkers of disease recurrence and prognosis to optimize patient selection for treatment with cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC), and through animal models to explore different treatment strategies for peritoneal surface malignancies (PSM).

Conditions

  • Pseudomyxoma Peritonei
  • Colorectal Carcinoma
  • Ovarian Carcinoma
  • Mesothelioma

Interventions

OTHER

Observational study.

Analysis of metastatic tissue and blood specimens collected from patients with PSM undergoing CRS-HIPEC. CRS: Removal of all macroscopically detectable tumor. HIPEC: Instillation of heated chemotherapy in the abdominal cavity to remove residual cancer disease.

Sponsors & Collaborators

  • The Research Council of Norway

    collaborator OTHER

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Kjersti Flatmark, MD PhD · Oslo University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2022-08-31
Completion
2027-08-31

Countries

  • Norway

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02073500 on ClinicalTrials.gov